Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy
Mario Guidotti,1 Caterina Barrilà,1 Serena Leva,1 Claudio De Piazza,1 Stefano Omboni21Department of Neurology, Valduce Hospital, Como, 2Italian Institute of Telemedicine, Varese, ItalyBackground: Migraine often occurs during weekends. The efficacy of frovatriptan, naproxen sodium, or...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/209474738a4f4feb827f2cb2ff3ba504 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:209474738a4f4feb827f2cb2ff3ba504 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:209474738a4f4feb827f2cb2ff3ba5042021-12-02T08:57:36ZSymptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy1176-63281178-2021https://doaj.org/article/209474738a4f4feb827f2cb2ff3ba5042013-01-01T00:00:00Zhttp://www.dovepress.com/symptomatic-or-prophylactic-treatment-of-weekend-migraine-an-open-labe-a11964https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Mario Guidotti,1 Caterina Barrilà,1 Serena Leva,1 Claudio De Piazza,1 Stefano Omboni21Department of Neurology, Valduce Hospital, Como, 2Italian Institute of Telemedicine, Varese, ItalyBackground: Migraine often occurs during weekends. The efficacy of frovatriptan, naproxen sodium, or no therapy for the acute or prophylactic treatment of weekend migraineurs was tested in an open-label, nonrandomized pilot study.Methods: Twenty-eight subjects (mean age 36 ± 12 years, including 18 females) suffering from migraine without aura were followed up for six consecutive weekends. No treatment was administered during the first two weekends. On the third and fourth weekends, patients were given frovatriptan 2.5 mg and on the fifth and sixth weekends naproxen sodium 500 mg. Treatment was taken on Saturday and Sunday morning, regardless of the occurrence of migraine. Efficacy was evaluated through a diary, where patients reported the severity of migraine on a scale from 0 (no migraine) to 10 (severe migraine) and use of rescue medication.Results: The migraine severity score was significantly lower with frovatriptan (4.8 [95% confidence interval (CI) 3.8–5.9]) than with naproxen sodium (5.7 [CI 5.1–6.4], P < 0.05 versus frovatriptan) or no therapy (6.6 [6.2–7.0], P < 0.01 versus frovatriptan). The difference in favor of frovatriptan was more striking in patients not taking rescue medication (frovatriptan, 1.9 [1.5–2.3]) versus naproxen sodium 3.6 [3.0–4.2], P < 0.001) and versus no therapy (5.1 [4.4–5.8], P < 0.001) and on the second day of treatment. The rate of use of rescue medication was significantly (P < 0.05) lower on frovatriptan (12.5%) than on naproxen sodium (31.3%) or no therapy (56.3%).Conclusion: This pilot study provides the first evidence of the efficacy of a second-generation triptan as symptomatic or prophylactic treatment for weekend migraine.Keywords: migraine, frovatriptan, naproxen sodium, weekendGuidotti MBarrilà CLeva SDe Piazza COmboni SDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 81-85 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Guidotti M Barrilà C Leva S De Piazza C Omboni S Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| description |
Mario Guidotti,1 Caterina Barrilà,1 Serena Leva,1 Claudio De Piazza,1 Stefano Omboni21Department of Neurology, Valduce Hospital, Como, 2Italian Institute of Telemedicine, Varese, ItalyBackground: Migraine often occurs during weekends. The efficacy of frovatriptan, naproxen sodium, or no therapy for the acute or prophylactic treatment of weekend migraineurs was tested in an open-label, nonrandomized pilot study.Methods: Twenty-eight subjects (mean age 36 ± 12 years, including 18 females) suffering from migraine without aura were followed up for six consecutive weekends. No treatment was administered during the first two weekends. On the third and fourth weekends, patients were given frovatriptan 2.5 mg and on the fifth and sixth weekends naproxen sodium 500 mg. Treatment was taken on Saturday and Sunday morning, regardless of the occurrence of migraine. Efficacy was evaluated through a diary, where patients reported the severity of migraine on a scale from 0 (no migraine) to 10 (severe migraine) and use of rescue medication.Results: The migraine severity score was significantly lower with frovatriptan (4.8 [95% confidence interval (CI) 3.8–5.9]) than with naproxen sodium (5.7 [CI 5.1–6.4], P < 0.05 versus frovatriptan) or no therapy (6.6 [6.2–7.0], P < 0.01 versus frovatriptan). The difference in favor of frovatriptan was more striking in patients not taking rescue medication (frovatriptan, 1.9 [1.5–2.3]) versus naproxen sodium 3.6 [3.0–4.2], P < 0.001) and versus no therapy (5.1 [4.4–5.8], P < 0.001) and on the second day of treatment. The rate of use of rescue medication was significantly (P < 0.05) lower on frovatriptan (12.5%) than on naproxen sodium (31.3%) or no therapy (56.3%).Conclusion: This pilot study provides the first evidence of the efficacy of a second-generation triptan as symptomatic or prophylactic treatment for weekend migraine.Keywords: migraine, frovatriptan, naproxen sodium, weekend |
| format |
article |
| author |
Guidotti M Barrilà C Leva S De Piazza C Omboni S |
| author_facet |
Guidotti M Barrilà C Leva S De Piazza C Omboni S |
| author_sort |
Guidotti M |
| title |
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| title_short |
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| title_full |
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| title_fullStr |
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| title_full_unstemmed |
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| title_sort |
symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy |
| publisher |
Dove Medical Press |
| publishDate |
2013 |
| url |
https://doaj.org/article/209474738a4f4feb827f2cb2ff3ba504 |
| work_keys_str_mv |
AT guidottim symptomaticorprophylactictreatmentofweekendmigraineanopenlabelnonrandomizedcomparisonstudyoffrovatriptanversusnaproxensodiumversusnotherapy AT barrilampagravec symptomaticorprophylactictreatmentofweekendmigraineanopenlabelnonrandomizedcomparisonstudyoffrovatriptanversusnaproxensodiumversusnotherapy AT levas symptomaticorprophylactictreatmentofweekendmigraineanopenlabelnonrandomizedcomparisonstudyoffrovatriptanversusnaproxensodiumversusnotherapy AT depiazzac symptomaticorprophylactictreatmentofweekendmigraineanopenlabelnonrandomizedcomparisonstudyoffrovatriptanversusnaproxensodiumversusnotherapy AT ombonis symptomaticorprophylactictreatmentofweekendmigraineanopenlabelnonrandomizedcomparisonstudyoffrovatriptanversusnaproxensodiumversusnotherapy |
| _version_ |
1718398289868488704 |